ReviewPharmaceuticals (Basel, Switzerland)2022

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing.

Afaf A El-Malah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.